OPELLA Trademark

Trademark Overview

On Thursday, December 7, 2023, a trademark application was filed for OPELLA with the United States Patent and Trademark Office. The USPTO has given the OPELLA trademark a serial number of 98303149. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Tuesday, March 10, 2026. This trademark is owned by Opella Healthcare Switzerland AG. The OPELLA trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing consumer information to consumers regarding products in the field of pharmaceuticals; providing commercial information to customers on pharmaceutical products
opella

General Information

Serial Number98303149
Word MarkOPELLA
Filing DateThursday, December 7, 2023
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateTuesday, March 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements

Goods and ServicesProviding consumer information to consumers regarding products in the field of pharmaceuticals; providing commercial information to customers on pharmaceutical products

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, December 7, 2023
Primary Code035
First Use Anywhere DateSunday, August 31, 2025
First Use In Commerce DateSunday, August 31, 2025

Trademark Owner History

Party NameOpella Healthcare Switzerland AG
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressRotkreuz 6343
CH
Party NameOpella Healthcare Switzerland AG
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressRotkreuz 6343
CH

Trademark Events

Event DateEvent Description
Thursday, December 7, 2023NEW APPLICATION ENTERED
Tuesday, March 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 11, 2024ASSIGNED TO EXAMINER
Wednesday, June 12, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 12, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 27, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, February 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 27, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 27, 2025SOU TEAS EXTENSION RECEIVED
Thursday, February 27, 2025SOU EXTENSION 1 FILED
Friday, February 28, 2025SOU EXTENSION 1 GRANTED
Friday, February 28, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 3, 2025TEAS STATEMENT OF USE RECEIVED
Monday, March 9, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 3, 2025USE AMENDMENT FILED
Monday, March 9, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 10, 2026SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 10, 2026NON-FINAL ACTION E-MAILED
Tuesday, March 10, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

opella providing information products commercial customers pharmaceutical pharmaceuticals field regarding consumer